[go: up one dir, main page]

ATE478091T1 - Anwendung des cpn104 polypeptids aus chlamydia pneumoniae oder dessen antikörper zur diagnose einer chlamydia infektion - Google Patents

Anwendung des cpn104 polypeptids aus chlamydia pneumoniae oder dessen antikörper zur diagnose einer chlamydia infektion

Info

Publication number
ATE478091T1
ATE478091T1 AT04713956T AT04713956T ATE478091T1 AT E478091 T1 ATE478091 T1 AT E478091T1 AT 04713956 T AT04713956 T AT 04713956T AT 04713956 T AT04713956 T AT 04713956T AT E478091 T1 ATE478091 T1 AT E478091T1
Authority
AT
Austria
Prior art keywords
chlamydia
cpn104
polypeptide
antibodies
diagnosis
Prior art date
Application number
AT04713956T
Other languages
English (en)
Inventor
Alice Dautry-Varsat
Agathe Subtil-Sands
Original Assignee
Pasteur Institut
Centre Nat Rech Scient
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pasteur Institut, Centre Nat Rech Scient filed Critical Pasteur Institut
Application granted granted Critical
Publication of ATE478091T1 publication Critical patent/ATE478091T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/295—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Chlamydiales (O)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT04713956T 2003-02-24 2004-02-24 Anwendung des cpn104 polypeptids aus chlamydia pneumoniae oder dessen antikörper zur diagnose einer chlamydia infektion ATE478091T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US44887903P 2003-02-24 2003-02-24
PCT/IB2004/000902 WO2004074318A2 (en) 2003-02-24 2004-02-24 Secreted chlamydia polypeptides, polynucleotides coding therefor, therapeutic and diagnostic uses thereof.

Publications (1)

Publication Number Publication Date
ATE478091T1 true ATE478091T1 (de) 2010-09-15

Family

ID=32908668

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04713956T ATE478091T1 (de) 2003-02-24 2004-02-24 Anwendung des cpn104 polypeptids aus chlamydia pneumoniae oder dessen antikörper zur diagnose einer chlamydia infektion

Country Status (7)

Country Link
US (3) US20040208890A1 (de)
EP (1) EP1597275B1 (de)
CN (1) CN1856505A (de)
AT (1) ATE478091T1 (de)
CA (1) CA2516971A1 (de)
DE (1) DE602004028705D1 (de)
WO (1) WO2004074318A2 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1856505A (zh) * 2003-02-24 2006-11-01 巴斯德研究院 分泌型衣原体多肽、其编码多核苷酸及其治疗和诊断用途
WO2006045308A2 (en) 2004-10-25 2006-05-04 Statens Serum Institut Chlamydia trachomatis antigens for vaccine and diagnostic use
US20090028891A1 (en) * 2004-11-11 2009-01-29 Queensland University Of Technology Chlamydia Antigens and Uses Thereof
EP1970708A1 (de) * 2007-03-07 2008-09-17 Mikrogen Molekularbiologische Entwicklungs-GmbH Biochip und Verfahren zum selektiven Nachweis von Chlamydia trachomatis-Infektionen
CA2683888A1 (en) * 2007-05-01 2008-11-06 The Board Of Regents Of The University Of Texas System Chlamydial antigens as reagents for diagnosis and treatment of chlamydial infection and disease
US7892567B2 (en) * 2007-10-01 2011-02-22 Board Of Regents, The University Of Texas System Methods and compositions for immunization against chlamydial infection and disease
JP4798125B2 (ja) * 2007-12-13 2011-10-19 株式会社デンソー 照度センサ
WO2010042206A1 (en) * 2008-10-09 2010-04-15 Board Of Regents, University Of Texas System Methods and compositions for chlamydial antigens for diagnosis and treatment of chlamydial infection and disease
CA2754618A1 (en) * 2009-03-06 2010-09-10 Novartis Ag Chlamydia antigens
US20120135025A1 (en) * 2010-10-20 2012-05-31 Genocea Biosciences, Inc. Chlamydia antigens and uses thereof
KR102282265B1 (ko) * 2014-01-23 2021-07-26 닛산 가가쿠 가부시키가이샤 배양 배지 조성물의 제조 방법

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5225539A (en) 1986-03-27 1993-07-06 Medical Research Council Recombinant altered antibodies and methods of making altered antibodies
CU22584A1 (es) 1995-11-17 1999-11-03 Centro Inmunologia Molecular Composiciones farmacéuticas que contienen un anticuerpo monoclonal que reconoce el antígeno de diferenciación leucocitario humano cd6 y sus usos para el diagnóstico y tratamiento de la psoriasis
US6183744B1 (en) 1997-03-24 2001-02-06 Immunomedics, Inc. Immunotherapy of B-cell malignancies using anti-CD22 antibodies
PT1032674E (pt) * 1997-11-21 2007-03-30 Serono Genetics Inst Sa Sequência genómica e polipéptidos (de chlamydia pneumoniae), seus fragmentos e suas utilizações, em particular para o diagnóstico, prevenção e tratamento de infacção
EP1854885B9 (de) * 1997-11-21 2011-03-16 Merck Serono Biodevelopment Äusseres Membranpolypeptid von Chlamydia pneumoniae sowie Fragmente davon und deren Verwendung, insbesondere zur Diagnose, Prävention und Behandlung einer Infektion
US7041490B1 (en) * 1997-11-28 2006-05-09 Serono Genetics Institute, S.A. Chlamydia trachomatis polynucleotides and vectors, recombinant host cells, DNA chips or kits containing the same
US6822071B1 (en) * 1998-11-12 2004-11-23 The Regents Of The University Of California Polypeptides from Chlamydia pneumoniae and their use in the diagnosis, prevention and treatment of disease
US6693176B1 (en) 1999-07-23 2004-02-17 University Of Massachusetts Antitumor antibodies, proteins, and uses thereof
DE60137449D1 (de) * 2000-12-14 2009-03-05 Pasteur Institut Sekretierte chlamydia polypeptide und verfahren zur identifizierung davon über ihre sekretion durch gramnegativen bakterientyp iii sekretionsweg
CN1856505A (zh) * 2003-02-24 2006-11-01 巴斯德研究院 分泌型衣原体多肽、其编码多核苷酸及其治疗和诊断用途
WO2005002619A2 (en) * 2003-06-26 2005-01-13 Chiron Corporation Immunogenic compositions for chlamydia trachomatis
US20070065837A1 (en) * 2005-09-21 2007-03-22 Qiagen Diagnostics Gmbh Methods and compositions for the detection of Chlamydia trachomatis

Also Published As

Publication number Publication date
EP1597275B1 (de) 2010-08-18
US20080213285A1 (en) 2008-09-04
WO2004074318A3 (en) 2005-03-24
US20040208890A1 (en) 2004-10-21
DE602004028705D1 (de) 2010-09-30
WO2004074318A2 (en) 2004-09-02
CN1856505A (zh) 2006-11-01
CA2516971A1 (en) 2004-09-02
EP1597275A2 (de) 2005-11-23
US20070003568A1 (en) 2007-01-04

Similar Documents

Publication Publication Date Title
ATE478091T1 (de) Anwendung des cpn104 polypeptids aus chlamydia pneumoniae oder dessen antikörper zur diagnose einer chlamydia infektion
MX2009005901A (es) Nuevos polipeptidos cristalinos de bacillus thuringiensis, polinucleotidos y composiciones de los mismos.
MX2007007602A (es) Agonistas del peptido 1 similar al glucagon, composiciones, metodos y usos.
BR0206346A (pt) Proteìnas inseticidas de bacillus thuringiensis
UA101301C2 (ru) ВЫДЕЛЕННОЕ АНТИТЕЛО ПРОТИВ IL-23pl 9 И ЕГО ПРИМЕНЕНИЕ
ATE497975T1 (de) Il-21-varianten
WO2005082077A3 (en) Novel bacillus thuringiensis crystal polypeptides, polynucleotides, and compositions thereof
EA200970131A1 (ru) Миметические антитела для glp-1 человека, композиции, способы и применения
WO2007141274A3 (en) Human binding molecules having killing activity against staphylococci and uses thereof
SG158145A1 (en) Vaccines against chlamydial infection
MX2010004179A (es) Anticuerpos anti-amiloide, composiciones, metodos y usos.
WO2009024327A3 (en) New proteins for use in human and animal staphylococcus infections
WO2007005647A3 (en) Polynucleotides and polypeptides of the il-12 family of cytokines
BRPI0409359A (pt) análogos quiméricos de somatostatina-dopamina
WO2005019264A3 (en) Human lxr alpha variants
IL212653A0 (en) Polypeptides of leishmania major and polynucleotides encoding same and vaccinal, therapeutical and diagnostic applications thereof
MXPA04006049A (es) Proteina secretada.
WO2006075253A3 (en) Peptides for desensitizing subjects allergic to dog hair and dander and compositions containing said peptides.
WO2008016385A3 (en) Deacylase polypeptides, deacylase polynucleotides, and methods of use thereof
ATE406438T1 (de) Menschliches homolog aus der familie der metalloproteasen
WO2002018576A3 (en) Compositions and methods relating to lung specific genes
WO2008015380A8 (en) Integral membrane protein of the pmp-22/emp/mp20/ claudin-like family
WO2003074553A3 (en) Expec-specific proteins, genes encoding them and uses thereof
WO2003093305A3 (en) Teneurin c-terminal associated peptides (tcap) and uses thereof
ATE473999T1 (de) Polypeptide und nukleinsäuren, die diese codieren

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties